ATBECHDE....FRGB..ITLILUNLSE........................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0239629A119871007EP86906533.01986092919870602enenen1985078266319850930US1986086917719860530US1986090059319860826US1987100719874119871007198741C12Q 1/ 68 A I enPOLYMORPHISMS RELATED TO LIPID METABOLISM PREDICTIVE OF ATHEROSCLEROSIS: ApoB, ApoCII, ApoE, ApoAIVfrPOLYMORPHISMES LIES AU METABOLISME DES LIPIDES ET PERMETTANT DE DECELER UNE PROPENSION A L'ARTERIOSCLEROSE: ApoB, ApoCII, ApoE, ApoAIVdePOLYMORPHISMEN, GEBUNDEN AM LIPIDENMETABOLISMUS MIT VORHERSAGE DER ATHEROSKLEROSE: APOB, APOCII, APOE, APOAIVBIOTECHNOLOGY RESEARCH PARTNERS, LTD.2450 Bayshore ParkwayMountain View California 94043USFROSSARD, Philippe, M.580 Arastradero, Apartment 304Palo Alto, CA 94306USGoldin, Douglas Michael, et alJ.A. KEMP & CO. 14, South Square Gray's InnLondon WC1R 5LXGBATBECHDEFRGBITLILUNLSEUS198600204819860929enWO198700205919870409198708